Malignant lymphoma (disorder)
Year Started: 2017
Collection of B cell Lymphoid Malignancies including CLL, HCL, SLL, FL,SMZL, MCL
- Access:
- Open in response to specific calls
- Type:
- Disease specific
- Status:
- In progress
- Consent restrictions:
- Outside EU access restriction, Xenograft restriction
Associated Data Type | Procurement Timeframe |
---|---|
Biomarker datasets | 0 - 3 months |
Clinical records | 0 - 3 months |
Followup records | 0 - 3 months |
Freezer temperature logs | 3 - 6 months |
Imaging data | 0 - 3 months |
Pathology records | 0 - 3 months |
Physiological/biochemical measurements | 3 - 6 months |
Primary care records | 0 - 3 months |
Quality indicators | 3 - 6 months |
Treatment records | 0 - 3 months |
Donor Ethnicity | 0 - 3 months |
Male
Adult (> 40 years)
101 - 500 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Peripheral blood mononuclear cells (PBMC) | Liquid nitrogen liquid phase | N/A | Affected | 75% -99% | |
Plasma | -60°C to -85°C | N/A | Affected | 11 - 25% | |
Serum | -60°C to -85°C | N/A | Affected | 11 - 25% |
Female
Adult (> 40 years)
101 - 500 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Peripheral blood mononuclear cells (PBMC) | Liquid nitrogen liquid phase | N/A | Affected | 75% -99% | |
Plasma | -60°C to -85°C | N/A | Affected | 11 - 25% | |
Serum | -60°C to -85°C | N/A | Affected | 11 - 25% |